StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 03/22/2013 -- StockRunway.com issues special report on the Stocks Under Analysts Focus: Excel Maritime Carriers Ltd (NYSE: EXM), Halozyme Therapeutics, (NASDAQ:HALO)
Excel Maritime Carriers Ltd (NYSE: EXM)‘s stock had its rating “neutral” reaffirmed by Zacks in a research memo given to stockholders on Thursday. They presently have a $0.75 price target on the stock.
What Zacks analysts have to say about Excel Maritime Carriers performance? Find in this report
Zacks‘ expert mentioned that they kept their long term Neutral recommendation on Excel Maritime (EXM). The firm has postponed announcing its third quarter and Q4 of last year financial results. In the meantime, the stock price has declined more than 66% in the previous year. This was mostly attributable to the dreary prediction of the drybulk shipping industry.
Excel Maritime Carriers Ltd (NYSE: EXM) shares exchanged above the trend line with positive change 13.33% during mid-day trading on Friday.
The company has a one year low of $0.36 and a one year high of $2.13. The stock’s 50-day moving average is presently $0.57. The company’s market cap is $95.1 million.
Baxter (BAX) and Halozyme Therapeutics (NASDAQ:HALO) declared that the European Medicines Agency’s Committee for Medicinal Products for Human Use has given a Positive Opinion to Baxter for the use of HyQvia as replacement therapy for adult patients with primary and secondary immunodeficiencies.
How shares of Halozyme were trending during Friday session? Find out here
The product is a mixture of human normal immunoglobulin and recombinant human hyaluronidase, which helps the dispersion and absorption of the IGSC.
After getting selling approval from the European Commission, Baxter intends to release HyQvia in selected regions in the European Union afterward this year.
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
For more information on this press release visit: http://www.sbwire.com/press-releases/stocks-under-analysts-focus-excel-maritime-carriers-ltd-nyse-exm-and-halozyme-therapeutics-nasdaqhalo-227526.htm